Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Effectiveness and safety of the PlasmaJet® Device in advanced stage ovarian carcinoma: a systematic review.

Nieuwenhuyzen-de Boer GM, van der Kooy J, van Beekhuizen HJ.

J Ovarian Res. 2019 Jul 31;12(1):71. doi: 10.1186/s13048-019-0545-x. Review.

2.

Systemic adverse events in imiquimod use for cervical intraepithelial neoplasia - A case series.

Wouters T, Hendriks N, Koeneman M, Kruse AJ, van de Sande A, van Beekhuizen HJ, Gerestein KG, Bekkers RLM, Piek JMJ.

Case Rep Womens Health. 2019 Mar 6;21:e00105. doi: 10.1016/j.crwh.2019.e00105. eCollection 2019 Jan.

3.

Retrospective study of a 16 year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: Prevalence of invasive and in-situ carcinoma, with follow-up.

Blok F, Dasgupta S, Dinjens WNM, Roes EM, van Beekhuizen HJ, Ewing-Graham PC.

Gynecol Oncol. 2019 May;153(2):326-334. doi: 10.1016/j.ygyno.2019.03.003. Epub 2019 Mar 18.

PMID:
30894273
4.

Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta.

Collins SL, Alemdar B, van Beekhuizen HJ, Bertholdt C, Braun T, Calda P, Delorme P, Duvekot JJ, Gronbeck L, Kayem G, Langhoff-Roos J, Marcellin L, Martinelli P, Morel O, Mhallem M, Morlando M, Noergaard LN, Nonnenmacher A, Pateisky P, Petit P, Rijken MJ, Ropacka-Lesiak M, Schlembach D, Sentilhes L, Stefanovic V, Strindfors G, Tutschek B, Vangen S, Weichert A, Weizsäcker K, Chantraine F; International Society for Abnormally Invasive Placenta (IS-AIP).

Am J Obstet Gynecol. 2019 Jun;220(6):511-526. doi: 10.1016/j.ajog.2019.02.054. Epub 2019 Mar 5.

PMID:
30849356
5.

[New opportunities for preventing ovarian carcinoma].

Verkuyl DAA, van Beekhuizen HJ.

Ned Tijdschr Geneeskd. 2019 Feb 1;163. pii: D3562. Dutch.

PMID:
30730681
6.

Evaluation of effectiveness of the PlasmaJet surgical device in the treatment of advanced stage ovarian cancer (PlaComOv-study): study protocol of a randomized controlled trial in the Netherlands.

Nieuwenhuyzen-de Boer GM, Hofhuis W, Reesink-Peters N, Ewing-Graham PC, Schoots IG, Beltman JJ, Piek JMJ, Baalbergen A, Kooi GS, van Haaften A, van Huisseling H, Haans L, Dorman M, van Beekhuizen HJ.

BMC Cancer. 2019 Jan 14;19(1):58. doi: 10.1186/s12885-019-5275-3.

7.

TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.

van de Sande AJM, Koeneman MM, Gerestein CG, Kruse AJ, van Kemenade FJ, van Beekhuizen HJ.

BMC Cancer. 2018 Jun 15;18(1):655. doi: 10.1186/s12885-018-4510-7.

8.

Generalized unprovoked vulvodynia; A retrospective study on the efficacy of treatment with amitriptyline, gabapentin or pregabalin.

van Beekhuizen HJ, Oost J, van der Meijden WI.

Eur J Obstet Gynecol Reprod Biol. 2018 Jan;220:118-121. doi: 10.1016/j.ejogrb.2017.10.026. Epub 2017 Oct 31.

PMID:
29202395
9.

Treatment of Cervical Intraepithelial Neoplasia: Patients Preferences for Surgery or Immunotherapy with Imiquimod.

Koeneman MM, Essers BA, Gerestein CG, van de Sande AJ, Litjens RJ, Boskamp D, Goossens MF, Beekhuizen HJ, Kruitwagen RF, Kruse AJ, Dirksen CD.

J Immunother. 2017 Feb 17. doi: 10.1097/CJI.0000000000000158. [Epub ahead of print]

PMID:
28221188
10.

Preliminary stop of the TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC) trial.

Koeneman MM, Kruse AJ, Kooreman LF, Zur Hausen A, Hopman AH, Sep SJ, Van Gorp T, Slangen BF, van Beekhuizen HJ, van de Sande AJ, Gerestein CG, Nijman HW, Kruitwagen RF.

BMC Cancer. 2017 Feb 7;17(1):110. doi: 10.1186/s12885-017-3108-9.

11.

TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.

Koeneman MM, Kruse AJ, Kooreman LFS, Zur Hausen A, Hopman AHN, Sep SJS, Van Gorp T, Slangen BFM, van Beekhuizen HJ, van de Sande M, Gerestein CG, Nijman HW, Kruitwagen RFPM.

BMC Cancer. 2016 Feb 20;16:132. doi: 10.1186/s12885-016-2187-3.

12.

Repeat sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma is feasible.

van Doorn HC, van Beekhuizen HJ, Gaarenstroom KN, van der Velden J, van der Zee AG, Oonk MH, de Hullu JA.

Gynecol Oncol. 2016 Mar;140(3):415-9. doi: 10.1016/j.ygyno.2016.01.013. Epub 2016 Jan 12.

PMID:
26797295
13.

The lack of clinical value of peritoneal washing cytology in high risk patients undergoing risk-reducing salpingo-oophorectomy: a retrospective study and review.

Blok F, Roes EM, van Leenders GJ, van Beekhuizen HJ.

BMC Cancer. 2016 Jan 14;16:18. doi: 10.1186/s12885-015-2011-5. Review.

14.

Venous thromboembolism at time of diagnosis of ovarian cancer: Survival differs in symptomatic and asymptomatic cases.

Heath OM, van Beekhuizen HJ, Nama V, Kolomainen D, Nobbenhuis MAE, Ind TEJ, Sohaib SA, Lofts FJ, Heenan S, Gore M, Banerjee S, Kaye SB, Barton DPJ.

Thromb Res. 2016 Jan;137:30-35. doi: 10.1016/j.thromres.2015.11.030. Epub 2015 Nov 22.

PMID:
26653367
15.

Physicians' Awareness, Attitudes, and Experiences Regarding Imiquimod Treatment of Vaginal and Cervical Intraepithelial Neoplasia.

Koeneman MM, van de Sande AJ, van Beekhuizen HJ, Gerestein KG, van de Laar R, Kruitwagen RF, Kruse AJ.

J Low Genit Tract Dis. 2016 Jan;20(1):75-9. doi: 10.1097/LGT.0000000000000158.

PMID:
26579838
16.

Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review.

de Witte CJ, van de Sande AJ, van Beekhuizen HJ, Koeneman MM, Kruse AJ, Gerestein CG.

Gynecol Oncol. 2015 Nov;139(2):377-84. doi: 10.1016/j.ygyno.2015.08.018. Epub 2015 Aug 31. Review.

PMID:
26335596
17.

Single-dose compared with multiple day antibiotic prophylaxis for cesarean section in low-resource settings, a randomized controlled, noninferiority trial.

Westen EH, Kolk PR, van Velzen CL, Unkels R, Mmuni NS, Hamisi AD, Nakua RE, Vlek AL, van Beekhuizen HJ.

Acta Obstet Gynecol Scand. 2015 Jan;94(1):43-9. doi: 10.1111/aogs.12517. Epub 2014 Oct 19.

PMID:
25263498
18.

Lymph node count at inguinofemoral lymphadenectomy and groin recurrences in vulvar cancer.

van Beekhuizen HJ, Auzin M, van den Einden LC, de Hullu JA, van der Velden J, Wildhagen MF, van Doorn HC.

Int J Gynecol Cancer. 2014 May;24(4):773-8. doi: 10.1097/IGC.0000000000000125.

PMID:
24662136
19.

A randomized controlled trial on the value of misoprostol for the treatment of retained placenta in a low-resource setting.

van Beekhuizen HJ, Tarimo V, Pembe AB, Fauteck H, Lotgering FK.

Int J Gynaecol Obstet. 2013 Sep;122(3):234-7. doi: 10.1016/j.ijgo.2013.03.029. Epub 2013 Jun 19.

PMID:
23791153
20.

Fibrin- and collagen-based matrices attenuate inflammatory and procoagulant responses in human endothelial cell cultures exposed to Staphylococcus aureus.

Heying R, Wolf C, Beekhuizen H, Moelleken ML, Jockenhoevel S, Hoylaerts MF, Schmidt KG, Schroten H.

Tissue Eng Part A. 2012 Jan;18(1-2):147-56. doi: 10.1089/ten.TEA.2011.0029. Epub 2011 Oct 3.

PMID:
21806488
21.
22.

Natural killer cells and HLA-G expression in the basal decidua of human placenta adhesiva.

van Beekhuizen HJ, Joosten I, Lotgering FK, Bulten J, van Kempen LC.

Placenta. 2010 Dec;31(12):1078-84. doi: 10.1016/j.placenta.2010.09.016. Epub 2010 Oct 16.

PMID:
20952056
23.

LL-37 directs macrophage differentiation toward macrophages with a proinflammatory signature.

van der Does AM, Beekhuizen H, Ravensbergen B, Vos T, Ottenhoff TH, van Dissel JT, Drijfhout JW, Hiemstra PS, Nibbering PH.

J Immunol. 2010 Aug 1;185(3):1442-9. doi: 10.4049/jimmunol.1000376. Epub 2010 Jul 7.

24.

Antimicrobial peptide hLF1-11 directs granulocyte-macrophage colony-stimulating factor-driven monocyte differentiation toward macrophages with enhanced recognition and clearance of pathogens.

van der Does AM, Bogaards SJ, Ravensbergen B, Beekhuizen H, van Dissel JT, Nibbering PH.

Antimicrob Agents Chemother. 2010 Feb;54(2):811-6. doi: 10.1128/AAC.00652-09. Epub 2009 Nov 23.

25.

Treatment of retained placenta with misoprostol: a randomised controlled trial in a low-resource setting (Tanzania).

van Beekhuizen HJ, Pembe AB, Fauteck H, Lotgering FK.

BMC Pregnancy Childbirth. 2009 Oct 23;9:48. doi: 10.1186/1471-2393-9-48.

26.

The number of multinucleated trophoblastic giant cells in the basal decidua is decreased in retained placenta.

van Beekhuizen HJ, Joosten I, de Groot AN, Lotgering FK, van der Laak J, Bulten J.

J Clin Pathol. 2009 Sep;62(9):794-7. doi: 10.1136/jcp.2009.065953.

PMID:
19734475
27.

Contribution of (sub)domains of Staphylococcus aureus fibronectin-binding protein to the proinflammatory and procoagulant response of human vascular endothelial cells.

Heying R, van de Gevel J, Que YA, Piroth L, Moreillon P, Beekhuizen H.

Thromb Haemost. 2009 Mar;101(3):495-504.

PMID:
19277411
28.

Staphylococcal peptidoglycan initiates an inflammatory response and procoagulant activity in human vascular endothelial cells: a comparison with highly purified lipoteichoic acid and TSST-1.

Mattsson E, Heying R, van de Gevel JS, Hartung T, Beekhuizen H.

FEMS Immunol Med Microbiol. 2008 Jan;52(1):110-7. Epub 2007 Nov 20.

30.
31.

Complications of obstructed labour: pressure necrosis of neonatal scalp and vesicovaginal fistula.

van Beekhuizen HJ, Unkels R, Mmuni NS, Kaiser M.

Lancet. 2006 Sep 30;368(9542):1210. No abstract available.

PMID:
17011948
32.

Sulprostone reduces the need for the manual removal of the placenta in patients with retained placenta: a randomized controlled trial.

van Beekhuizen HJ, de Groot AN, De Boo T, Burger D, Jansen N, Lotgering FK.

Am J Obstet Gynecol. 2006 Feb;194(2):446-50.

PMID:
16458644
33.

Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells.

Lee JC, Koerten H, van den Broek P, Beekhuizen H, Wolterbeek R, van den Barselaar M, van der Reijden T, van der Meer J, van de Gevel J, Dijkshoorn L.

Res Microbiol. 2006 May;157(4):360-6. Epub 2005 Nov 2.

PMID:
16326077
34.

Gamma irradiation or CD4+-T-cell depletion causes reactivation of latent Salmonella enterica serovar Typhimurium infection in C3H/HeN mice.

van Diepen A, van de Gevel JS, Koudijs MM, Ossendorp F, Beekhuizen H, Janssen R, van Dissel JT.

Infect Immun. 2005 May;73(5):2857-62.

35.

Effect of maternal anti-HPA-1a antibodies and polyclonal IVIG on the activation status of vascular endothelial cells.

Radder CM, Beekhuizen H, Kanhai HH, Brand A.

Clin Exp Immunol. 2004 Jul;137(1):216-22.

36.

Irradiation of mechanically-injured human arterial endothelial cells leads to increased gene expression and secretion of inflammatory and growth promoting cytokines.

Wondergem J, Wedekind LE, Bart CI, Chin A, van der Laarse A, Beekhuizen H.

Atherosclerosis. 2004 Jul;175(1):59-67.

PMID:
15186947
37.

Effects of multiple doses of ionizing radiation on cytokine expression in rat and human cells.

Boerma M, Schutte-Bart CI, Wedekind LE, Beekhuizen H, Wondergem J.

Int J Radiat Biol. 2003 Nov;79(11):889-96.

PMID:
14698957
38.

Role of magnetic resonance imaging in the diagnosis of incarceration of the gravid uterus.

van Beekhuizen HJ, Bodewes HW, Tepe EM, Oosterbaan HP, Kruitwagen R, Nijland R.

Obstet Gynecol. 2003 Nov;102(5 Pt 2):1134-7.

PMID:
14607032
39.
41.

Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens.

van den Berg BM, David S, Beekhuizen H, Mooi FR, van Furth R.

Vaccine. 2000 Dec 8;19(9-10):1118-28.

PMID:
11137247
42.
43.

Altered gene expression in Staphylococcus aureus upon interaction with human endothelial cells.

Vriesema AJ, Beekhuizen H, Hamdi M, Soufan A, Lammers A, Willekens B, Bakker O, Welten AG, Veltrop MH, van De Gevel JS, Dankert J, Zaat SA.

Infect Immun. 2000 Apr;68(4):1765-72.

44.

Conference report: the 10th Annual Endothelium Symposium, Leiden, The Netherlands.

Beekhuizen H, Deruiter MC.

Endothelium. 1999;7(1):51-5. No abstract available.

PMID:
10599560
45.

Antibiotic-induced cell wall fragments of Staphylococcus aureus increase endothelial chemokine secretion and adhesiveness for granulocytes.

van Langevelde P, Ravensbergen E, Grashoff P, Beekhuizen H, Groeneveld PH, van Dissel JT.

Antimicrob Agents Chemother. 1999 Dec;43(12):2984-9.

46.

Bacterial species- and strain-dependent induction of tissue factor in human vascular endothelial cells.

Veltrop MH, Beekhuizen H, Thompson J.

Infect Immun. 1999 Nov;67(11):6130-8.

47.

Infection of human endothelial cells with Staphylococcus aureus induces the production of monocyte chemotactic protein-1 (MCP-1) and monocyte chemotaxis.

Tekstra J, Beekhuizen H, Van De Gevel JS, Van Benten IJ, Tuk CW, Beelen RH.

Clin Exp Immunol. 1999 Sep;117(3):489-95.

48.

Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract.

van den Berg BM, Beekhuizen H, Willems RJ, Mooi FR, van Furth R.

Infect Immun. 1999 Mar;67(3):1056-62.

50.

Endothelial cell adhesion molecules in inflammation and postischemic reperfusion injury.

Beekhuizen H, van de Gevel JS.

Transplant Proc. 1998 Dec;30(8):4251-6. Review. No abstract available.

PMID:
9865357

Supplemental Content

Loading ...
Support Center